To access any content or REGISTER in less than 3 minutes.
Filters
Therapeutic areas
Filters
CARIVALAN® Carvedilol + Ivabradine (CARIVALAN® 6.25mg/5mg, CARIIVALAN® 12.5mg/5mg & CARIVALAN® 25mg/5mg) are indicated as substitution therapy in adult patients with normal sinus rhythm.
Product information
CORALAN® Ivabradine (CORALAN® 5mg & CORALAN® 7.5mg) are indicated for symptomatic treatment of chronic stable angina pectoris; treatment of chronic heart failure.
Product information
COVERAM® Perindopril + Amlodipine (COVERAM® 5mg/5mg, COVERAM® 5mg/10mg, COVERAM® 10mg/5mg & COVERAM® 10mg/10mg) are indicated as substitution therapy for treatment of essential hypertension and/or stable coronary artery disease.
Product information
COVERSYL® Perindopril (COVERSYL® 5mg & COVERSYL® 10mg) are for the treatment of arterial hypertension, congestive heart failure; prevention of stroke recurrence in combination with Indapamide in patients with a history of cerebrovascular disease; stable coronary artery disease.
COVERSYL® PLUS Perindopril + Indapamide (COVERSYL® PLUS 5mg/1.25mg & COVERSYL® PLUS 10mg/2.5mg) are for the treatment of essential hypertension, in adults, in patients whose blood pressure is not adequately controlled on perindopril alone.
DAFLON® Diosmin + Hesperidin (DAFLON® 500 & DAFLON® 1000) are recommended for the treatment of venous circulation disorders (heavy legs, pain, restless legs) and functional symptoms related to acute hemorrhoidal attack.
Product information
DIAMICRON® Gliclazide (DIAMICRON® 80mg & DIAMICRON® MR 60mg) are for non-insulin-dependent diabetes (type 2) in adults, in association with dietary measures and with exercise.
Product information
NATRILIX® SR Indapamide (NATRILIX® SR 1.5mg) is indicated in essential hypertension in adults.
Product information
NATRIXAM® Indapamide = Amlodipine (NATRIXAM® 1.5mg/5mg & NATRIXAM®1.5mg/10mg) are indicated as substitution therapy for treatment of essential hypertension.
Product information
ROZUOR® Rosuvastatin + Ezetimbe (ROZUOR® 10mg/10mg & ROZUOR® 10mg/10mg) are indicated as adjunct to diet for treatment of primary hypercholesterolemia as substitution therapy in adult patients adequately controlled with the individual substances.
Product information
TRIPLIXAM® Perindopril + Indapamide + Amlodipine (TRIPLIXAM® 5mg/1.25mg/5mg, TRIPLIXAM® 5mg/1.25mg/10mg & TRIPLIXAM® 10mg/2.5mg/10mg) are indicated as substitution therapy for treatment of essential hypertension, in patients already controlled with perindopril/indapamide
Product information
TRIVERAM® Atorvastatin + Perindopril + Amlodipne (TRIVERAM® Initio 10mg/5mg/5mg, TRIVERAM® 20mg/5mg/5mg & TRIVERAM® Forte 40mg/10mg/10mg) are indicated for the treatment of essential hypertension and/or stable coronary artery disease, in association with primary hypercholesterolemia or mixed hyperlipidemia
Product information
VALDOXAN® Agomelatine (VALDOXAN® 25mg) is indicated for the treatment of major depressive episodes in adults.
Product information
VASTAREL® Trimetazidine (VASTAREL® 20mg) & (VASTAREL® MR 35mg) are for the preventive treatment of episodes of angina pectoris; Adjuvant symptomatic treatment of vertigo and tinnitus; Adjuvant treatment of visual disorders of circulatory origin. / Trimetazidine (VASTAREL® OD 80mg) is an add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies
VIACORAM® Perindopril + Amlodipine (VIACORAM® Initio 3.5mg/2.5mg & VIACORAM® 7mg/5mg) are indicated for treatment of essential hypertension in adults.
Product information